April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

April 01, 2025

Utilizing Staff for Patient Adherence

Here, I discuss the primary reasons for patient nonadherence and how, specifically, allied staff can play a role in increasing the likelihood of patients adhering to their follow-up visits and prescribed treatment plans for their ocular conditions.

Optometric Management

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 31, 2025

Microplastics Linked to Cardiovascular Disease

Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.

Conexiant

March 31, 2025

Hormone Therapy Boosts Semaglutide Weight Loss

At 12 months, women on hormone therapy achieved 16% total body weight loss with semaglutide, compared to 12% in those not using hormone therapy, researchers reported.

Conexiant

March 28, 2025

Mango Intake Linked to Improved Insulin Sensitivity

Fasting insulin levels were significantly lower with mango intake, according to a new study.

Conexiant

March 28, 2025

T2D: Non-traditional CVD Risk Factors

Investigators identify and rank non-traditional risk factors for cardiovascular disease prediction.

Conexiant

March 28, 2025

Cancer–Heart Death Link Exposed

Colorectal cancer patients face up to 45% higher cardiovascular mortality risk within two years of diagnosis, with Black patients and those under 50 experiencing the greatest danger, according to research presented at ACC.25.

Conexiant